Last reviewed · How we verify

Genesa (ARBUTAMINE)

FDA-approved approved Small molecule Quality 30/100

Genesa (Arbutamine) is a small molecule drug that targets the beta-1 adrenergic receptor. It was originally developed and is currently owned by a pharmaceutical company. Genesa is used for cardiac function studies and was FDA approved in 1997. The drug is off-patent and has no active generic manufacturers. As an off-patent drug, its commercial status is limited.

At a glance

Generic nameARBUTAMINE
Drug classarbutamine
TargetBeta-1 adrenergic receptor
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved
First approval1997

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions